| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | United States | 4 | |
| #3 | Australia | 2 | |
| #4 | Brazil | 2 | |
| #5 | Canada | 2 | |
| #6 | Israel | 2 | |
| #7 | Republic of Korea | 2 | |
| #8 | Taiwan | 2 | |
| #9 | WIPO (World Intellectual Property Organization) | 2 | |
| #10 | China | 1 | |
| #11 | Hong Kong | 1 | |
| #12 | Hungary | 1 | |
| #13 | Montenegro | 1 | |
| #14 | Mexico | 1 | |
| #15 | New Zealand | 1 | |
| #16 | Serbia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Computer technology | |
| #4 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Electric digital data processing |
| # | Name | Total Patents |
|---|---|---|
| #1 | Di Naro Antonio Francesco | 25 |
| #2 | Antonio Francesco Di Naro | 3 |
| Publication | Filing date | Title |
|---|---|---|
| KR20200103003A | Quantitative cellular method for determining the biological activity of anti-CD26 ligand | |
| US2019352417A1 | Anti-cd26 antibodies and uses thereof | |
| TW201607957A | Anti-cd26 antibodies and uses thereof | |
| EP2767549A1 | Anti-CD26 antibodies and uses thereof |